SCHEMBL5792006

SCHEMBL5792006

O=C(O)c1cc[n+](O)c2cc(Cl)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TSHR P16473 2/20 0.46
TP53 P04637 1/20 0.46
CASP1 P29466 1/20 0.46
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
F7 P08709 1/20 0.42
F3 P13726 1/20 0.42
KDM4E B2RXH2 4/20 0.38
HSD17B10 Q99714 2/20 0.38
MCL1 Q07820 2/20 0.38
BCKDK O14874 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
CYP2C9 P11712 3/20 0.38
HPGD P15428 2/20 0.38
PTGES O14684 1/20 0.38
ALOX5 P09917 1/20 0.38
CASP7 P55210 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11325463 0.72 SMN1; SMN2 (0.63) ALDH1A1SMN1; SMN2TSHRTP53CASP1
SCHEMBL19644240 0.67 PTPN1 (0.66) ALDH1A1SMN1; SMN2TSHRTP53CASP1
SCHEMBL5759442 0.67 NR4A1 (0.50) ALDH1A1SMN1; SMN2TSHRCA1CA2
SCHEMBL31522177 0.67 PTPN1 (0.66) ALDH1A1SMN1; SMN2TSHRTP53CASP1
SCHEMBL11433375 0.66 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2TSHRTP53CASP1
SCHEMBL19514758 0.65 ALDH1A1 (0.71) ALDH1A1SMN1; SMN2TSHRTP53CASP1
SCHEMBL1000440 0.65 ALDH1A1 (0.71) ALDH1A1SMN1; SMN2TSHRTP53CASP1
SCHEMBL5762904 0.64 CYP1A2 (0.58) ALDH1A1SMN1; SMN2TSHRTP53CASP1
Hydrochloric Acid SCHEMBL10902309 0.64 TSHR (0.68) ALDH1A1SMN1; SMN2TSHRTP53CASP1
SCHEMBL224469 0.64 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2TSHRTP53CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633737-A1 QUINOLYL AMIDE DERIVATIVES AS CCR-5 ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2006-03-15 EP disclosed
US-20050020605-A1 Quinolyl amide derivatives as CCR-5 antagonists SCHERING AKTIENGESELLSCHAFT (DE) 2005-01-27 US disclosed
WO-2004113323-A1 QUINOLYL AMIDE DERIVATIVES AS CCR-5 ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020605-A1 Quinolyl amide derivatives as CCR-5 antagonists CCRL2, CCR5, CCR1 ALDH1A1 2065/4885SMN1; SMN2 4482/4885TSHR 1606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.